Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-07 Sale |
2025-04-07 8:10 pm |
OmniAb Inc. | OABI | Berkman Charles S Chief Legal Officer |
7,206 | $2 | $14,412 | 475,709 (Direct) |
View |
| 2025-02-18 Sale |
2025-02-19 8:50 pm |
OmniAb Inc. | OABI | Berkman Charles S Chief Legal Officer |
15,470 | $3.6753 | $56,857 | 973,534 (Direct) |
View |
| 2025-01-21 Sale |
2025-01-22 5:41 pm |
OmniAb Inc. | OABI | Berkman Charles S Chief Legal Officer |
25,489 | $3.24 | $82,584 | 343,190 (Direct) |
View |
| 2024-12-09 Sale |
2024-12-10 4:47 pm |
OmniAb Inc. | OABI | Berkman Charles S Chief Legal Officer |
8,022 | $4.13 | $33,131 | 422,330 (Direct) |
View |
| 2024-04-08 Sale |
2024-04-09 6:37 pm |
OmniAb Inc. | OABI | Berkman Charles S Chief Legal Officer |
6,954 | $5.27 | $36,648 | 407,183 (Direct) |
View |
| 2022-11-01 Sale |
2022-11-03 9:08 pm |
OmniAb Operations Inc. | Berkman Charles S CLO & Secretary |
52,587 | $0 | $0 | 35,810 (Direct) |
View | |
| 2022-11-01 Sale |
2022-11-03 9:06 pm |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S Former Executive Officer |
11,944 | $0 | $0 | 23,825 (Direct) |
View |
| 2021-02-04 Sale |
2021-02-05 5:03 pm |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S SVP, Gen. Counsel & Secretary |
18,097 | $178.5 | $3,230,376 | 35,861 (Direct) |
View |
| 2020-06-04 Sale |
2020-06-05 4:07 pm |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S SVP, Gen. Counsel & Secretary |
11,146 | $118.59 | $1,321,775 | 40,877 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-07 Exercise |
2025-04-07 8:10 pm |
N/A N/A |
OmniAb Inc. | OABI | Berkman Charles S Chief Legal Officer |
13,542 | $0 | 475,709 (Direct) |
View |
| 2025-02-18 Option Award |
2025-02-19 8:50 pm |
N/A N/A |
OmniAb Inc. | OABI | Berkman Charles S Chief Legal Officer |
393,750 | $0 | 973,534 (Direct) |
View |
| 2025-02-15 Exercise |
2025-02-19 8:50 pm |
N/A N/A |
OmniAb Inc. | OABI | Berkman Charles S Chief Legal Officer |
29,156 | $0 | 973,534 (Direct) |
View |
| 2025-01-17 Option Award |
2025-01-22 5:41 pm |
N/A N/A |
OmniAb Inc. | OABI | Berkman Charles S Chief Legal Officer |
45,294 | $0 | 343,190 (Direct) |
View |
| 2024-12-07 Exercise |
2024-12-10 4:47 pm |
N/A N/A |
OmniAb Inc. | OABI | Berkman Charles S Chief Legal Officer |
15,621 | $0 | 422,330 (Direct) |
View |
| 2022-11-01 Option Award(A) |
2024-04-23 5:42 pm |
N/A N/A |
OmniAb Inc. | OABI | Berkman Charles S Chief Legal Officer |
366,511 | $0 | 305,412 (Direct) |
View |
| 2024-04-07 Exercise |
2024-04-09 6:37 pm |
N/A N/A |
OmniAb Inc. | OABI | Berkman Charles S Chief Legal Officer |
13,541 | $0 | 407,183 (Direct) |
View |
| 2024-02-16 Option Award |
2024-02-20 6:22 pm |
N/A N/A |
OmniAb Inc. | OABI | Berkman Charles S Chief Legal Officer |
284,375 | $0 | 838,549 (Direct) |
View |
| 2024-02-15 Exercise |
2024-02-20 6:22 pm |
N/A N/A |
OmniAb Inc. | OABI | Berkman Charles S Chief Legal Officer |
21,322 | $0 | 838,549 (Direct) |
View |
| 2024-02-15 Tax Withholding |
2024-02-20 6:22 pm |
N/A N/A |
OmniAb Inc. | OABI | Berkman Charles S Chief Legal Officer |
7,609 | $5.54 | 838,549 (Direct) |
View |
| 2024-01-02 Exercise |
2024-01-03 5:42 pm |
N/A N/A |
OmniAb Inc. | OABI | Berkman Charles S Chief Legal Officer |
17,556 | $0 | 381,121 (Direct) |
View |
| 2024-01-02 Tax Withholding |
2024-01-03 5:42 pm |
N/A N/A |
OmniAb Inc. | OABI | Berkman Charles S Chief Legal Officer |
7,195 | $6.25 | 381,121 (Direct) |
View |
| 2023-12-07 Exercise(A) |
2023-12-12 6:26 pm |
N/A N/A |
OmniAb Inc. | OABI | Berkman Charles S Chief Legal Officer |
15,622 | $0 | 126,360 (Direct) |
View |
| 2023-12-07 Tax Withholding |
2023-12-11 7:21 pm |
N/A N/A |
OmniAb Inc. | OABI | Berkman Charles S Chief Legal Officer |
5,403 | $4.85 | 715,100 (Direct) |
View |
| 2023-12-07 Exercise |
2023-12-11 7:21 pm |
N/A N/A |
OmniAb Inc. | OABI | Berkman Charles S Chief Legal Officer |
15,622 | $0 | 715,100 (Direct) |
View |
| 2023-04-07 Option Award |
2023-04-11 7:11 pm |
N/A 2033-04-07 |
OmniAb Inc. | OABI | Berkman Charles S Chief Legal Officer |
284,375 | $0 | 658,314 (Direct) |
View |
| 2023-02-15 Tax Withholding |
2023-02-17 7:50 pm |
N/A N/A |
OmniAb Inc. | OABI | Berkman Charles S Chief Legal Officer |
9,543 | $3.8 | 373,939 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 5:06 pm |
N/A N/A |
OmniAb Inc. | OABI | Berkman Charles S See Remarks |
46,864 | $0 | 383,482 (Direct) |
View |
| 2022-12-28 Tax Withholding |
2022-12-30 5:00 pm |
N/A N/A |
OmniAb Inc. | OABI | Berkman Charles S See Remarks |
6,518 | $3.66 | 336,618 (Direct) |
View |
| 2022-12-07 Option Award |
2022-12-09 6:00 pm |
N/A 2032-12-07 |
OmniAb Inc. | OABI | Berkman Charles S See Remarks |
175,477 | $0 | 175,477 (Direct) |
View |
| 2022-12-01 Tax Withholding |
2022-12-05 9:41 pm |
N/A N/A |
OmniAb Inc. | OABI | Berkman Charles S See Remarks |
10,580 | $3.35 | 343,136 (Direct) |
View |
| 2022-11-01 Option Award |
2022-11-03 9:16 pm |
N/A 2025-02-10 |
OmniAb Inc. | OABI | Berkman Charles S See Remarks |
790,522 | $0 | 790,522 (Direct) |
View |
| 2022-11-01 Option Award |
2022-11-03 9:08 pm |
N/A 2032-05-05 |
OmniAb Operations Inc. | Berkman Charles S CLO & Secretary |
51,219 | $0 | 35,810 (Direct) |
View | |
| 2022-06-10 Option Award |
2022-06-14 5:55 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S SVP, Gen. Counsel & Secretary |
5,375 | $0 | 35,769 (Direct) |
View |
| 2022-05-05 Option Award |
2022-05-09 8:10 pm |
N/A 2032-05-05 |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S SVP, Gen. Counsel & Secretary |
20,126 | $0 | 20,126 (Direct) |
View |
| 2022-02-15 Tax Withholding |
2022-02-16 8:24 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S SVP, Gen. Counsel & Secretary |
1,578 | $123.68 | 30,394 (Direct) |
View |
| 2022-01-26 Option Award |
2022-01-28 8:42 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S SVP, Gen. Counsel & Secretary |
6,237 | $0 | 31,972 (Direct) |
View |
| 2022-01-26 Tax Withholding |
2022-01-28 8:42 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S SVP, Gen. Counsel & Secretary |
2,156 | $113.68 | 31,972 (Direct) |
View |
| 2021-02-15 Tax Withholding |
2021-02-18 6:28 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S SVP, Gen. Counsel & Secretary |
1,015 | $172.46 | 27,891 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-05 5:03 pm |
N/A 2021-02-03 |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S SVP, Gen. Counsel & Secretary |
10,446 | $0 | 35,861 (Direct) |
View |
| 2021-01-25 Option Award |
2021-01-27 7:02 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S SVP, Gen. Counsel & Secretary |
3,736 | $0 | 43,512 (Direct) |
View |
| 2021-01-25 Tax Withholding |
2021-01-27 7:02 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S SVP, Gen. Counsel & Secretary |
509 | $156.1 | 43,512 (Direct) |
View |
| 2021-01-25 Tax Withholding |
2021-01-27 7:02 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S SVP, Gen. Counsel & Secretary |
830 | $156.01 | 43,512 (Direct) |
View |
| 2020-06-30 Other |
2020-07-01 8:06 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S SVP, Gen. Counsel & Secretary |
238 | $89.03 | 41,353 (Direct) |
View |